Company / EPS (Diluted)
Humana EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$20.00
FY2025
5-year range
$20.00 / $25.31
FY2021-FY2025
Trend
-9.4%
vs FY2024
Sector context
#8 of 159
Health Care
What the data says
Among 159 Health Care companies, Humana is in the top 5% for eps (diluted). EPS (Diluted) has declined for 3 consecutive years, from $25.31 in FY2022 to $20.00 in FY2025.
Based on SEC 10-K filings.
20.00 in FY2025 with a 5-year CAGR of +10.5%. Top quartile in the Health Care sector.
Declined from $22.67 to $20.00 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -7.5%
- 5-Year CAGR
- +10.5%
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 159This company $20.00 Sector average $2.35
▼
+750.3% above sector average
Key checks
Key Insights
- Humana's eps (diluted) has declined for 3 consecutive years.
- In FY2025, eps (diluted) decreased 9.4% year-over-year.
- Ranks #8 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 3.80 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $20.00 | -9.4% |
| FY2024 | $22.08 | -2.6% |
| FY2023 | $22.67 | -10.4% |
| FY2022 | $25.31 | +25.9% |
| FY2021 | $20.10 | +65.3% |
| FY2020 | $12.16 | -27.7% |
| FY2019 | $16.81 | +313.0% |
| FY2018 | $4.07 | -51.8% |
| FY2017 | $8.44 | +14.7% |
| FY2016 | $7.36 | -4.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026